TGFB1 and cancer: A previous study has defined six major immune subtypes (ISs) across pan-cancer in TCGA: IS1 (wound healing), IS2 (IFN-γ dominant), IS3 (inflammatory), IS4 (lymphocyte depleted), IS5 (immunologically quiet), and IS6 (TGF-β dominant) (36).